Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Int J Urol. 2011 Jun;18(6):472-6. doi: 10.1111/j.1442-2042.2011.02765.x. Epub 2011 Apr 11.
We assessed whether adequately functioning parenchyma is preserved in patients with pre-existing chronic kidney disease (CKD) after partial nephrectomy (PN) compared with those who underwent radical nephrectomy (RN). A total of 95 patients with pre-existing CKD who underwent curative surgery for pathological T1a-T2N0M0 renal cell carcinoma with a follow-up period of 12 months or more were the subject of the present study. Of these, 51 patients underwent RN, and 44 PN. Renal function was assessed by using the estimated glomerular filtration rate (e-GFR). We classified the subjects into two groups according to the preoperative e-GFR: preoperative e-GFR 45-59 mL/min/1.73 m(2) (68 patients); and 30-44 mL/min/1.73 m(2) (27 patients). In the former group, the probability of freedom from new onset of e-GFR <45 mL/min/1.73 m(2) stemmed from the significant difference between the PN and RN groups (P = 0.006; PN: 2 years 64%; RN: 2 years 22%). In contrast, in the latter group, the probability of freedom from new onset of e-GFR <30 mL/min/1.73 m(2) was not associated with a significant difference between PN and RN group (P = 0.80). Overall survival and the number of the patients who went on to develop end-stage renal disease requiring renal replacement therapy between PN and RN were not significantly different in each group. Death from renal cell carcinoma was not noted in either group. PN could significantly prevent development to late-stage CKD in patients with preoperative e-GFR 45-59 mL/min/1.73 m(2) compared with RN. Patients with preoperative e-GFR 30-44 mL/min/1.73 m(2) should be reviewed in a more strict study.
我们评估了与根治性肾切除术(RN)相比,在接受部分肾切除术(PN)的预先存在慢性肾脏病(CKD)患者中是否保留了足够功能的实质。本研究共纳入 95 例接受根治性手术治疗 T1a-T2N0M0 期病理肾细胞癌的预先存在 CKD 患者,随访时间 12 个月或以上。其中,51 例行 RN,44 例行 PN。通过估算肾小球滤过率(e-GFR)评估肾功能。根据术前 e-GFR 将患者分为两组:术前 e-GFR 45-59 mL/min/1.73 m(2)(68 例)和 30-44 mL/min/1.73 m(2)(27 例)。在前一组中,PN 和 RN 组之间的差异显著导致新发生 e-GFR<45 mL/min/1.73 m(2)的可能性为无事件(P=0.006;PN:2 年 64%;RN:2 年 22%)。相比之下,在后一组中,PN 和 RN 组之间新发生 e-GFR<30 mL/min/1.73 m(2)的可能性无显著差异(P=0.80)。每组的总体生存率和需要肾脏替代治疗的终末期肾病患者数量在 PN 和 RN 之间无显著差异。两组均未发生肾细胞癌死亡。与 RN 相比,PN 可显著预防术前 e-GFR 45-59 mL/min/1.73 m(2)的患者进展为晚期 CKD。对于术前 e-GFR 30-44 mL/min/1.73 m(2)的患者,应进行更严格的研究。